Glycolic Acid

Glycolic Acid

SCHEMBL174591

CC1(Cl)CNCCc2ccccc21.O=C(O)CO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.41
HTR2C P28335 4/20 0.41
DRD2 P14416 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
LMNA P02545 1/20 0.34
BLM P54132 1/20 0.34
PNMT P11086 1/20 0.34
CD44 P16070 1/20 0.34
MAOB P27338 1/20 0.34
HTR2B P41595 1/20 0.34
HDAC9 Q9UKV0 1/20 0.33
PRCP P42785 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL175159 0.92 HTR2A (0.41) HTR2AHTR2CDRD2SLC6A2SLC6A4
Malonic Acid SCHEMBL174326 0.92 HTR2A (0.41) HTR2AHTR2CDRD2SLC6A2SLC6A4
Adipic Acid SCHEMBL173981 0.89 L3MBTL1 (0.41) HTR2AHTR2CDRD2SLC6A2SLC6A4
Citric Acid SCHEMBL173747 0.87 SLC13A5 (0.39) HTR2AHTR2CLMNABLM
SCHEMBL173319 0.87 HTR2A (0.51) HTR2AHTR2CDRD2SLC6A2SLC6A4
Alpha-Ketoglutaric Acid SCHEMBL174485 0.86 HTR2A (0.37) HTR2AHTR2CDRD2SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL5317898 0.85 HTR2A (0.50) HTR2AHTR2CDRD2SLC6A2SLC6A4
Phosphoric Acid SCHEMBL174685 0.84 HTR2A (0.44) HTR2AHTR2CDRD2SLC6A2SLC6A4
SCHEMBL174465 0.83 HTR2C (0.43) HTR2AHTR2CDRD2SLC6A2SLC6A4
Glycolic Acid SCHEMBL12504961 0.77 HTR2C (0.64) HTR2CDRD2PNMTCD44MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611427-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT& xA; Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030927-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed